What is the intrinsic value of MJNA?
As of 2026-04-29, the Intrinsic Value of Medical Marijuana Inc (MJNA) is
0.02 USD. This MJNA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.00 USD, the upside of Medical Marijuana Inc is
12,047.42%.
Is MJNA undervalued or overvalued?
Based on its market price of 0.00 USD and our intrinsic valuation, Medical Marijuana Inc (MJNA) is undervalued by 12,047.42%.
MJNA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(1.09) - (0.10) |
(0.18) |
-89425.1% |
| DCF (Growth 10y) |
(0.14) - (1.44) |
(0.24) |
-121631.0% |
| DCF (EBITDA 5y) |
(0.00) - 0.00 |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(0.01) - (0.01) |
(1,234.50) |
-123450.0% |
| Fair Value |
0.02 - 0.02 |
0.02 |
12,047.42% |
| P/E |
0.02 - 0.10 |
0.06 |
30585.5% |
| EV/EBITDA |
0.00 - 0.00 |
0.00 |
1130.0% |
| EPV |
(0.00) - (0.00) |
(0.00) |
-2148.6% |
| DDM - Stable |
0.00 - 0.01 |
0.01 |
3919.4% |
| DDM - Multi |
0.05 - 0.09 |
0.06 |
30221.7% |
MJNA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.99 |
| Beta |
-4.33 |
| Outstanding shares (mil) |
9,959.02 |
| Enterprise Value (mil) |
-0.41 |
| Market risk premium |
4.60% |
| Cost of Equity |
16.44% |
| Cost of Debt |
5.00% |
| WACC |
5.45% |